Creative Bioarray Provides A Reliable Endothelial Cell Resources for Vascular Research and Drug Screening
Creative Bioarray announced the release of its reliable and reproducible endothelial cell resources to accelerate vascular disease modeling, drug screening, and vascular tissue engineering applications.
New York, United States – January 20, 2022 /MarketersMEDIA/ —
Creative Bioarray, one of the world’s leading biotechnology products and services providers, focuses on developing unique technologies and cutting-edge platforms to facilitate the investigation of life science research. With high-quality products and satisfactory services, Creative Bioarray can cooperate with customers to develop and perform flexible custom-designed experiments that meet unique needs and goals. Recently, Creative Bioarray announced the release of its reliable and reproducible endothelial cell resources to accelerate vascular disease modeling, drug screening, and vascular tissue engineering applications.
Endothelial cells are cells that line the inner surfaces of blood vessels and lymphatic vessels, forming an interface between circulating blood or lymph in the lumen and the rest of the vessel wall. Endothelial cells act as a permeable barrier to regulate the passage of substances between the bloodstream and surrounding tissues. In basic research, endothelial cells are critical in applications related to wound healing, angiogenesis, the blood-brain barrier (BBB), inflammatory processes, diabetes, and other cardiovascular diseases.
Endothelial cells from Creative Bioarray have been isolated from human normal and diseased donors in various tissues and animals such as mice, rats, monkeys, and bovines with high purity, low passage, rigorous characterization, and performance testing. These cells can be applied in vascular biology, inflammation, angiogenesis, atherosclerosis, blood coagulation, vasoconstriction and vasodilation, and tubule formation assays.
The endothelial cell culture medium provided by Creative Bioarray is optimized for the culture of normal human primary endothelial cells and microvascular cells. CreativeBioarray offers optimized complete kits including basal media and associated supplements. With Creative Bioarray’s Endothelial Cell Culture Media, customers will get consistently reproducible results! Creative Bioarray balances and replenishes primary endothelial cells to maximize endothelial cell life expectancy.
Compared to other commercially available media, endothelial cells will grow faster in Creative Bioarray medium and will maintain better morphology, supporting the growth of primary endothelial cells during at least 15 population doublings. The available cells provided by Creative Bioarray include human umbilical vein endothelial cells, coronary artery endothelial cells, aortic endothelial cells, and human lung microvascular endothelial cells.
“We provide high-quality endothelial cell growth media to support your research, including diabetes-related complications related to cardiovascular function, immune response mechanisms, and graft rejection, as well as 3D endothelium-engineered tissues.” said Hannah Cole, the marketing director of Creative Bioarray, she also claimed, “we can also provide customized solutions to satisfy specific needs and accelerate the progress of your research.”
About Creative Bioarray
Creative Bioarray is dedicated to offering customers innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house expert support, Creative Bioarray has already countenanced research all around the world.
Contact Info:
Name: Hannah Cole
Email: Send Email
Organization: Creative Bioarray
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Phone: 1 631 386 8241
Website: https://www.creative-bioarray.com/
Source: MarketersMEDIA
Release ID: 89060783
Copyright © 1999-2013 SproutNews.com
